It runs through December 31, 2027, and requires meeting BMI-based clinical criteria
Safety and tolerability remain important considerations
Although the first of many GLP-1 agonists exenatide, brand Byetta was approved for type 2 diabetes in 2005, poison centers did not handle many exposure cases until several of these agents were approved for weight loss, and their popularity skyrocketed
Most wellness clinics recommend avoiding excessive use and focusing instead on: hydration protein intake resistance training sleep quality calorie balance This creates better long-term results than increasing injection frequency unnecessarily
Obesity and overweight, with or without metabolic dysregulation, pose vexing problems for many patients with mood, anxiety, or psychotic disorders
It tends to lean toward stronger and faster rather than easy nightly routine. Nasal Spray vs Injection: Comparison Table Heres a simple side-by-side comparison of the major differences: While both methods aim to support relaxation and restorative sleep, nasal spray is ideal for convenience and steady results, while injections may appeal to those seeking faster, more potent effects